COMPARISON OF PROLIFERATION AND IMMUNOPHENOTYPE OF MSC, OBTAINEDFROM BONE MARROW, ADIPOSE TISSUE AND UMBILICAL CORD

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract


Mesenchymal stem cells (MSC) can be applied for treatment of different diseases. Human MSC have been isolated from bone marrow, adipose tissue, umbilical cord blood. umbilical cord MSCs (uC- MSC) are obtained during birth with non-invasive, non-traumatic methods and thus seem a good candidate for clinical practice instead of bone-marrow MSC (BM-MSC). It is yet unknown wheth- er the immunophenotype and proliferation capacity of uC-MSC are similar to adipose-derived stem cells (AdSCs) or BM-MSC. The goal of this research was to study the immunophenotype and prolifer- atiion capacity of uC-MSC, AdSCs and BM-MSC. The results indicated that MSC of different origin had similar morphological and immunophenotypic characteristics with minor differences. uC-MSC differed from other cultures by constant level of Cd105 expression, the presence of minor Cd10 - and Cd13 - populations and higher proliferative activity. BM-MSC were characterized by reduced expres- sion levels of Cd90, compared with the uC-MSCs and AdSCs. These data confirm the similarity of uC-MSC with BM-MSCs and AdSCs and the possibility of their use in clinical practice instead of hard-to-obtain BM-MSC.

Full Text

Restricted Access

About the authors

A A Aisenstadt

North-West State Medical university named after I.I. Mechnicov

N I Enukashvili

T L Zolina

L V Alexandrov

A B Smoljaninov

North-West State Medical university named after I.I. Mechnicov

References

  1. Пиневич, А. А. Характеристика мезенхимальных стромальных клеток при раке молочной железы / А. А. Пиневич, М. П. Самойлови., О. А. Шашкова, Н. Л. Вартанян, В. Н. Полысалов, Л. Н. Киселева, А. В. Карташев, А. А. Айзенштадт, В.Б. Климович // Клеточные технологии в биологии и медицине. - 2014. - N 2. - С. 84-91.
  2. Климович, В. Б. Иммуномодулирующая активность мезенхимальных стромальных (стволовых) клеток / В. Б. Климович // Медицинская иммунология. -2014. - Т. 16, № 2. - С. 107-126.
  3. Friedenstein A. J., Chailakhjan R. K., Lalykina K. S. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells //Cell Proliferation. - 1970. - Т.3. - №. 4. - С. 393-403.
  4. Erices A., Conget P., Minguell J. J. Mesenchymal progenitor cells in human umbilical cord blood //British journal of haematology. - 2000. - Т.109. - №. 1. - С. 235-242.
  5. Fukuchi Y., Nakajima H., Sugiyama D., Hirose I., Kitamura T., Tsuji K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential //Stem cells. - 2004. - Т. 22. - №. 5. - С. 649-658.
  6. Zvaifler N.J., Marinova-Mutafchieva L., Adams G., Edwards C.J., Moss J., Burger J.A. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2000 V.2. P. 477- 488.
  7. Nagatomo K., Komaki M., Sekiya I., Sakaguchi Y., Noguchi K., Oda S. Stem cell properties of human periodontal ligament cells. J Periodontal Res. Arthritis research. - 2000. - Т. 2. - №. 6. - С. 477-488.
  8. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. // Cytotherapy. - 2006. - Т. 8. - №. 4. - С. 315-317.
  9. Rada T, Reis RL, Gomes ME. 2011. Distinct stem cells subpopulations isolated from human adipose tissue exhibit different chondrogenic and osteogenic differentiation potential // Stem Cell Reviews and Reports. - 2011. - Т. 7. - №. 1. - С. 64-76.
  10. Siegel G, Kluba T, Hermanutz-Klein U, Bieback K, Northoff H, Schäfer R. Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells // BMC medicine. - 2013. - Т. 11. - №. 1. - С. 146.
  11. Campioni D, Rizzo R, Stignani M, Melchiorri L, Ferrari L, Moretti S, Russo A, Bagnara GP, Bonsi L, Alviano F, Lanzoni G, Cuneo A, Baricordi OR, Lanza F. 2009. A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs //Cytometry Part B: Clinical Cytometry. - 2009. - Т. 76. - №. 3. - С. 225-230.
  12. Baksh D., Yao R., Tuan R.S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow //Stem cells. - 2007. - Т. 25. - №. 6. - С. 1384-1392.
  13. Sumitomo M., Shen R., Walburg M., Dai J., Geng Y., Navarro D., Boileau G., Papandreou C.N., Giancotti F.G., Knudsen B., Nanus D.M. Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling. // Journal of Clinical Investigation. - 2000. - Т. 106. - №. 11. - С. 1399-1407.
  14. Farias V.A., Linares-Fernández J.L., Peñalver J.L., Payá Colmenero J.A., Ferrón G.O., Duran E.L., Fernández R.M., Olivares E.G., O'Valle F., Puertas A., Oliver F.J., Ruiz de Almodóvar J.M. Human umbilical cord stromal stem cell express CD10 and exert contractile properties //Placenta. - 2011. - Т. 32. - №. 1. - С. 86-95.
  15. Mina-Osorio P. The moonlighting enzyme CD13: old and new functions to target //Trends in molecular medicine. - 2008. - Т. 14. - №. 8. - С. 361-371.
  16. Musina R.A., Bekchanova E.S., Sukhikh G.T. Comparison of mesenchymal stem cells obtained from different human tissues //Bulletin of experimental biology and medicine. - 2005. - Т. 139. - №. 4. - С. 504-509.
  17. Vishnubalaji R., Al-Nbaheen M., Kadalmani B., Aldahmash A., Ramesh T. Comparative investigation of the differentiation capability of bone-marrow-and adipose-derived mesenchymal stem cells by qualitative and quantitative analysis //Cell and tissue research. - 2012. - Т. 347. - №. 2. - С. 419-427.
  18. Panepucci R.A., Siufi J.L., Silva W.Ar, Proto-Siquiera R., Neder L., Orellana M., Rocha V., Covas D.T., Zago M.A. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells //Stem cells. - 2004. - Т. 22. - №. 7. - С. 1263-1278.
  19. Weiss M.L., Troyer D.L. Stem cells in the umbilical cord //Stem cell reviews. - 2006. - Т. 2. - №. 2. - С. 155-162.
  20. Ishige I., Nagamura-Inoue T., Honda M.J., Harnprasopwat R., Kido M., Sugimoto M., Nakauchi H., Tojo A. Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton's jelly explants of human umbilical cord //International journal of hematology. - 2009. - Т. 90. - №. 2. - С. 261-269.
  21. Campioni D., Rizzo R., Stignani M., Melchiorri L., Ferrari L., Moretti S., Russo A., Bagnara G.P., Bonsi L., Alviano F., Lanzoni G., Cuneo A., Baricordi O.R., Lanza F. A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs //Cytometry Part B: Clinical Cytometry. - 2009. - Т.76. - №. 3. - С. 225-230.
  22. Campioni D., Moretti S., Ferrari L., Punturieri M., Castoldi G.L., Lanza F. Immunophenotypic heterogeneity of bone marrow-derived mesenchymal stromal cells from patients with hematologic disorders: correlation with bone marrow microenvironment. //Haematologica. - 2006. - Т. 91. - №. 3. - С. 364-368.
  23. Rada T., Reis R.L., Gomes M.E. Distinct stem cells subpopulations isolated from human adipose tissue exhibit different chondrogenic and osteogenic differentiation potential //Stem Cell Reviews and Reports. - 2011. - Т. 7. - №. 1. - С. 64-76.
  24. Aslan H., Zilberman Y., Kandel L., Liebergall M., Oskouian R.J., Gazit D., Gazit Z. Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells //Stem Cells. - 2006. - Т. 24. - №. 7. - С. 1728-1737.
  25. Jiang T., Liu W., Lv X., Sun H, Zhang L, Liu Y, Zhang WJ, Cao Y, Zhou G. Potent in vitro chondrogenesis of CD105 enriched human adipose-derived stem cells //Biomaterials. - 2010. - Т. 31. - №. 13. - С. 3564-3571.Jin H.J., Park S.K., Oh W., Yang Y.S., Kim S.W., Choi S.J. Down-regulation of CD105 is associated with multi-lineage differentiation in human umbilical cord blood-derived mesenchymal stem cells //Biochemical and biophysical research communications. - 2009. - Т. 381. - №. 4. - С. 676-681.
  26. Anderson P., Carrillo-Gálvez A.B., García-Pérez A.,Cobo M., Martín F. CD105 (endoglin)-negative murine mesenchymal stromal cells define a new multipotent subpopulation with distinct differentiation and immunomodulatory capacities //PloS one. - 2013. - Т. 8. - №. 10. - С. e76979.
  27. Le Blanc K., Rasmusson I., Gotherstrom C. Mesenchymal stem cells inhibit the expression of CD25 (interleukin_2 receptor) and CD38 on phytohaemagglutinin activated lymphocytes //Scandinavian journal of immunology. - 2004. - Т. 60. - №. 3. - С. 307-315.
  28. Sotiropoulou P.A., Perez S.A., Gritzapis A.D., Baxevanis C.N., Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells //Stem cells. - 2006. - Т. 24. - №. 1. - С. 74-85.
  29. Newman R.E., Yoo D., LeRoux M.A., Danilkovitch-Miagkova A. Treatment of inflammatory diseases with mesenchymal stem cells //Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets-Inflammation & Allergy). - 2009. - Т. 8. - №. 2. - С. 110-123.
  30. Franquesa M., Herrero E., Torras J., Ripoll E., Flaquer M., Gomà M., Lloberas N., Anegon I., Cruzado J.M., Grinyó J.M., Herrero-Fresneda I. Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model //Stem cells and development. - 2012. - Т. 21. - №. 17. - С. 3125-3135.
  31. Crop M.J., Baan C.C., Korevaar S.S., Ijzermans J.N., Pescatori M., Stubbs A.P., van Ijcken W.F., Dahlke M.H., Eggenhofer E., Weimar W., Hoogduijn M.J. Inflammatory conditions affect gene expression and function of human adipose tissue-derivedmesenchymal stem cells. //Clinical & Experimental Immunology. - 2010. - Т.162. - №. 3. - С. 474-486.
  32. Ruggeri L., Capanni M., Martelli M.F., Velardi A. Cellular therapy: exploiting NK cell alloreactivity in transplantation. //Current opinion in hematology. - 2001. - Т. 8. - №.6. - С. 355-359.

Statistics

Views

Abstract - 255

PDF (Russian) - 143

Cited-By


PlumX

Refbacks

  • There are currently no refbacks.

Copyright (c) 2015 Aisenstadt A.A., Enukashvili N.I., Zolina T.L., Alexandrov L.V., Smoljaninov A.B.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies